LataMed AI Evaluates Installment Payment Integration With Cashea to Improve Healthcare Access in Latin America
June 11th, 2026 12:55 PM
By: Newsworthy Staff
LataMed AI Corp. has initiated a strategic evaluation to integrate Cashea's buy-now-pay-later platform, aiming to reduce financial barriers and boost patient engagement in its healthcare ecosystem.

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence company, announced it has begun an operational, technical, and commercial evaluation to potentially integrate installment-based healthcare payments through Cashea, a leading buy-now-pay-later financial technology platform in Venezuela. The initiative is designed to reduce upfront financial barriers for patients seeking private healthcare services within the LataMed AI ecosystem, which includes consultations, diagnostics, wellness programs, and other eligible offerings.
Management believes that improving payment accessibility could enhance patient engagement, increase healthcare utilization, and strengthen platform adoption. By addressing affordability challenges, the company aims to bolster its position as a technology-enabled healthcare marketplace serving patients, providers, and partners across Latin America. The potential integration aligns with LataMed AI's broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a scalable healthcare marketplace.
Dr. Kevin Rodan Levy, CEO of LataMed AI Corp., stated: "We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while expanding the reach and utility of our healthcare ecosystem." He added that such initiatives could strengthen patient acquisition, improve engagement, and support long-term platform growth.
The company has not yet entered a definitive commercial agreement, and completion of any integration remains subject to further discussions, technical requirements, regulatory review, and customary business conditions. LataMed AI intends to provide updates as material developments occur. For more information, visit https://latamed.ai or review SEC filings at www.sec.gov.
This evaluation marks a strategic step for LataMed AI as it seeks to leverage fintech partnerships to overcome financial obstacles in healthcare, particularly in emerging markets where out-of-pocket costs often deter patients from seeking timely care. The initiative could serve as a model for integrating payment flexibility into digital health platforms, potentially driving adoption and improving health outcomes in the region.
Source Statement
This news article relied primarily on a press release disributed by NewMediaWire. You can read the source press release here,
